1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with s6c sarafotoxin in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (s6c sarafotoxin) | Trials (s6c sarafotoxin) | Recent Studies (post-2010) (s6c sarafotoxin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 595 | 3 | 37 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Koster, BM; Elferink, JG | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and s6c sarafotoxin
Article | Year |
---|---|
Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c.
Topics: Calcium; Chemotaxis, Leukocyte; Cytoplasm; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Humans; Interleukin-8; Leukotriene B4; Lymphocyte Activation; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peptide Fragments; Peptides, Cyclic; Platelet Activating Factor; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1996 |